| 06/09/2026 8:21 PM | BJERKHOLT ERIC (1197350) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:20 PM | BJERKHOLT ERIC (1197350) Reporting Mirum Pharmaceuticals (1759425) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/02/2026 6:50 PM | Fischer Laurent (1379344) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 6:50 PM | Mirum Pharmaceuticals (1759425) Issuer Ramasastry Saira (1547959) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 6:50 PM | Cardon Lon (1854337) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 6:50 PM | Mirum Pharmaceuticals (1759425) Issuer Walbert Timothy P (1349376) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 6:50 PM | Mirum Pharmaceuticals (1759425) Issuer Peetz Christopher (1614740) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 4:33 PM | Mirum Pharmaceuticals (1759425) Subject Peetz Christopher (1614740) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/01/2026 3:04 PM | Mirum Pharmaceuticals (1759425) Subject Ramasastry Saira (1547959) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/18/2026 7:32 PM | Mirum Pharmaceuticals (1759425) Issuer Ramasastry Saira (1547959) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:06 PM | Mirum Pharmaceuticals (1759425) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for MIRM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Mirum Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/06/2026 3:04 PM | Mirum Pharmaceuticals (1759425) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/04/2026 7:00 AM | Mirum Pharmaceuticals (1759425) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/27/2026 3:12 PM | BlackRock, Inc. (2012383) Filed by Mirum Pharmaceuticals (1759425) Subject | Form SCHEDULE 13G/A | |
| 04/27/2026 7:07 AM | Mirum Pharmaceuticals (1759425) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/24/2026 8:57 AM | Mirum Pharmaceuticals (1759425) Filer | Form ARS | |
| 04/23/2026 3:39 PM | Mirum Pharmaceuticals (1759425) Filer | Form DEF 14A | |
| 04/23/2026 3:42 PM | Mirum Pharmaceuticals (1759425) Filer | Form DEFA14A | |
| 04/16/2026 7:40 PM | Mirum Pharmaceuticals (1759425) Issuer Ramasastry Saira (1547959) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 3:11 PM | Mirum Pharmaceuticals (1759425) Subject Ramasastry Saira (1547959) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/08/2026 3:13 PM | Mirum Pharmaceuticals (1759425) Filer | Form 8-K/A | |
| 03/17/2026 6:30 PM | Mirum Pharmaceuticals (1759425) Issuer Peetz Christopher (1614740) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 6:30 PM | Howe Jolanda (1974200) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 6:30 PM | Mirum Pharmaceuticals (1759425) Issuer Radovich Peter (1650131) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 6:30 PM | Mirum Pharmaceuticals (1759425) Issuer Ramasastry Saira (1547959) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 6:30 PM | Mirum Pharmaceuticals (1759425) Issuer Quan Joanne (1670138) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 6:30 PM | BJERKHOLT ERIC (1197350) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 6:00 PM | Mirum Pharmaceuticals (1759425) Subject Quan Joanne (1670138) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/17/2026 6:03 PM | BJERKHOLT ERIC (1197350) Reporting Mirum Pharmaceuticals (1759425) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/17/2026 5:50 PM | Mirum Pharmaceuticals (1759425) Subject Peetz Christopher (1614740) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/17/2026 5:55 PM | Howe Jolanda (1974200) Reporting Mirum Pharmaceuticals (1759425) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/17/2026 5:58 PM | Mirum Pharmaceuticals (1759425) Subject Radovich Peter (1650131) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/16/2026 3:04 PM | Mirum Pharmaceuticals (1759425) Subject Ramasastry Saira (1547959) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/25/2026 3:32 PM | Mirum Pharmaceuticals (1759425) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/13/2026 12:09 PM | EVENTIDE ASSET MANAGEMENT, LLC (1442891) Filed by Mirum Pharmaceuticals (1759425) Subject | Form SCHEDULE 13G/A | |
| 02/03/2026 8:45 PM | Howe Jolanda (1974200) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 8:45 PM | Mirum Pharmaceuticals (1759425) Issuer Peetz Christopher (1614740) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 8:45 PM | Mirum Pharmaceuticals (1759425) Issuer Radovich Peter (1650131) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/02/2026 7:29 PM | Howe Jolanda (1974200) Reporting Mirum Pharmaceuticals (1759425) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/02/2026 7:21 PM | Mirum Pharmaceuticals (1759425) Subject Peetz Christopher (1614740) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/02/2026 7:25 PM | Mirum Pharmaceuticals (1759425) Subject Radovich Peter (1650131) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Read this warning immediately (Ad) Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776.
One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift. Read Porter Stansberry's full breakdown and protect your wealth now |
| 01/30/2026 5:30 PM | Mirum Pharmaceuticals (1759425) Issuer Peetz Christopher (1614740) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/30/2026 5:30 PM | Mirum Pharmaceuticals (1759425) Issuer Radovich Peter (1650131) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/30/2026 5:30 PM | BJERKHOLT ERIC (1197350) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/30/2026 5:30 PM | Mirum Pharmaceuticals (1759425) Issuer Quan Joanne (1670138) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/30/2026 5:30 PM | Howe Jolanda (1974200) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/28/2026 5:40 PM | Mirum Pharmaceuticals (1759425) Subject Peetz Christopher (1614740) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/28/2026 5:43 PM | Mirum Pharmaceuticals (1759425) Subject Radovich Peter (1650131) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/28/2026 5:44 PM | BJERKHOLT ERIC (1197350) Reporting Mirum Pharmaceuticals (1759425) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/28/2026 5:47 PM | Howe Jolanda (1974200) Reporting Mirum Pharmaceuticals (1759425) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/27/2026 3:12 PM | Frazier Life Sciences IX, L.P. (1720320) Filed by Mirum Pharmaceuticals (1759425) Subject | Form SCHEDULE 13D/A | |
| 01/27/2026 3:14 PM | Heron Patrick J (1365617) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 3:10 PM | Mirum Pharmaceuticals (1759425) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/23/2026 4:30 PM | Mirum Pharmaceuticals (1759425) Issuer Peetz Christopher (1614740) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/23/2026 4:30 PM | Mirum Pharmaceuticals (1759425) Issuer Radovich Peter (1650131) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/23/2026 4:30 PM | BJERKHOLT ERIC (1197350) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/23/2026 4:30 PM | Mirum Pharmaceuticals (1759425) Issuer Quan Joanne (1670138) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/23/2026 4:30 PM | Howe Jolanda (1974200) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/15/2026 3:02 PM | Mirum Pharmaceuticals (1759425) Subject Ramasastry Saira (1547959) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/12/2026 7:40 AM | Mirum Pharmaceuticals (1759425) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/02/2026 3:24 PM | Mirum Pharmaceuticals (1759425) Issuer Peetz Christopher (1614740) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/23/2025 5:50 PM | GREY MICHAEL G (1240122) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/23/2025 5:52 PM | Mirum Pharmaceuticals (1759425) Issuer Ramasastry Saira (1547959) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/22/2025 3:03 PM | Mirum Pharmaceuticals (1759425) Subject Ramasastry Saira (1547959) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/19/2025 3:15 PM | Mirum Pharmaceuticals (1759425) Issuer Ramasastry Saira (1547959) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/19/2025 3:05 PM | GREY MICHAEL G (1240122) Reporting Mirum Pharmaceuticals (1759425) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/19/2025 3:06 PM | Mirum Pharmaceuticals (1759425) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/19/2025 7:30 AM | Mirum Pharmaceuticals (1759425) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/18/2025 3:09 PM | Mirum Pharmaceuticals (1759425) Subject Ramasastry Saira (1547959) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/08/2025 7:00 AM | Mirum Pharmaceuticals (1759425) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/05/2025 11:46 AM | JANUS HENDERSON GROUP PLC (1274173) Filed by Mirum Pharmaceuticals (1759425) Subject | Form SCHEDULE 13G/A | |
| 11/21/2025 3:09 PM | GREY MICHAEL G (1240122) Reporting Mirum Pharmaceuticals (1759425) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/20/2025 3:21 PM | Mirum Pharmaceuticals (1759425) Issuer Peetz Christopher (1614740) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 3:52 PM | Mirum Pharmaceuticals (1759425) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/04/2025 4:26 PM | Frazier Life Sciences IX, L.P. (1720320) Filed by Mirum Pharmaceuticals (1759425) Subject | Form SCHEDULE 13D/A | |
| 11/04/2025 3:02 PM | Mirum Pharmaceuticals (1759425) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/04/2025 3:05 PM | Mirum Pharmaceuticals (1759425) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 09/12/2025 7:00 PM | BJERKHOLT ERIC (1197350) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/12/2025 7:00 PM | Brege Laura (1365619) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/11/2025 3:04 PM | Brege Laura (1365619) Reporting Mirum Pharmaceuticals (1759425) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/10/2025 4:50 PM | Mirum Pharmaceuticals (1759425) Issuer Ramasastry Saira (1547959) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/09/2025 3:47 PM | Mirum Pharmaceuticals (1759425) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 08/20/2025 4:17 PM | Frazier Life Sciences IX, L.P. (1720320) Filed by Mirum Pharmaceuticals (1759425) Subject | Form SCHEDULE 13D/A | |
| 08/14/2025 10:15 AM | JANUS HENDERSON GROUP PLC (1274173) Filed by Mirum Pharmaceuticals (1759425) Subject | Form SCHEDULE 13G/A | |
| 08/12/2025 6:57 PM | Mirum Pharmaceuticals (1759425) Issuer Peetz Christopher (1614740) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/12/2025 7:00 PM | BJERKHOLT ERIC (1197350) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/08/2025 3:49 PM | Mirum Pharmaceuticals (1759425) Issuer Peetz Christopher (1614740) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/08/2025 3:50 PM | Howe Jolanda (1974200) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/03/2025 5:48 PM | Howe Jolanda (1974200) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/03/2025 12:13 PM | Howe Jolanda (1974200) Reporting Mirum Pharmaceuticals (1759425) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/13/2025 3:18 PM | Fairey William (1727275) Reporting Mirum Pharmaceuticals (1759425) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad) Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. Get the name and ticker of Louis Navellier's #1 AI stock free |